Facebook Twitter LinkedIn Google Plus RSS

Arno Therapeutics appoints new CFO

By

Flemington-based Arno Therapeutics, a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, announced Thursday it has appointed Lawrence A. Kenyon as chief financial officer.

According to the announcement, Kenyon will report to president and chief executive officer Glenn Mattes, and will direct financial reporting and controls.

Kenyon has spent over a decade leading the financial function at publicly-traded healthcare companies including several in the oncology space.  He has over 25-years of senior-level finance and accounting experience, the announcement said.

ALSO ON NJBIZ:

SLIDESHOW: NJBIZ names Best 50 Women in Business for 2014

Choose New Jersey receives excellence in economic development award

Tech entrepreneurs debate challenges of raising capital at NJ Spark Summit

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!